ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab.

Rajat Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.